LATAM Loratadine Market Size & Outlook, 2025-2033


LATAM Loratadine Market Insights

  • According to Reed Intelligence analysis, the LATAM Loratadine Market size stood at USD 16.69 Million in 2024 and is forecasted to reach USD 22.95 Million by 2033.
  • The market is projected to grow at a CAGR of 3.61% between 2026 and 2033.
  • By segment, Oral was the leading Type in terms of market size in 2024.
  • Topical is expected to be the most lucrative Type segment, exhibiting the fastest growth throughout the forecast period.

Other Key Findings


  • The global Loratadine Market size saw LATAM holding a share of 9.82% in 2024.
  • United States is forecasted to account for the leading share of the global market by 2033.
  • In LATAM, Mexico is forecasted to be the fastest-expanding market, projected to reach USD 6.84 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 16.69 Million
Market Size In 2033 USD 22.95 Million
Largest segment Oral
Units Revenue in USD Million
CAGR 3.61% (2025-2033)
Segmnetation Covered
LATAM
  1. Brazil
  2. Mexico
  3. Argentina
  4. Colombia
  5. Chile
Type
  1. Oral
  2. Topical
Dosage Form
  1. Tablets
  2. Syrups
  3. Creams
  4. Gels
Strength
  1. 5 mg
  2. 10 mg
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends